Status:
UNKNOWN
Study of the Intestinal Microbiota of Patients With Systemic Sclerosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
The term gut microbiota describes the entire intestinal microbial communities. Studies have established the important role played by the gut microbiome in modulating vital functions of the healthy hos...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Patient with a confirmed diagnosis of systemic sclerosis according to international criteria, before or after the start date of this study.
- Non-opposition of the patient
Exclusion
- Subject under guardianship, curatorship or safeguard of justice
- Subject with state medical aid (AME)
- Subject does not speak French
- Subject unable to answer questions or express himself/herself
- Taking antibiotics or a colonic preparation within 6 weeks prior to stool collection will be a temporary contraindication to stool collection. The patient may be included, other usual care samples may be taken, but the stool sample will be deferred and taken at a later date.
Key Trial Info
Start Date :
March 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04791280
Start Date
March 31 2021
End Date
September 1 2023
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Saint Antoine - service de médecine interne
Paris, France, 75012